ALS is a neurodegenerative disorder marked by progressively worsening muscle weakness and neurological dysfunction.| ALS News Today
Clene said it would submit additional CNM-Au8 clinical trial data and analysis to the FDA ahead of a planned meeting later this year.| ALS News Today
CNM-Au8 is an experimental liquid treatment for people with ALS that intends to increase cell energy.| ALS News Today
Category archive page for News.| ALS News Today
Margarida Maia is a science writer for ALS News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
There are several ALS treatment options that can help manage symptoms and slow the progression of the disease.| ALS News Today
The risk of death was nearly 60% lower in ALS patients given the experimental oral therapy CNM-Au8 than for an external placebo group, data show.| ALS News Today
ALS is a progressive neurological disorder that damages motor neurons. Learn more about types, causes, symptoms, diagnosis, and treatment.| ALS News Today